
CRA International (CRAI) | Financial Analysis & Statements
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Mar 2025Income Metrics
Revenue
181.9M
Gross Profit
61.5M
33.82%
Operating Income
25.5M
14.05%
Net Income
18.0M
9.90%
EPS (Diluted)
$2.62
Balance Sheet Metrics
Total Assets
590.4M
Total Liabilities
363.1M
Shareholders Equity
227.3M
Debt to Equity
1.60
Cash Flow Metrics
Operating Cash Flow
-80.8M
Free Cash Flow
-81.0M
Revenue & Profitability Trend
CRA International Income Statement From 2020 to 2024
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Revenue | 687.4M | 624.0M | 590.9M | 565.9M | 508.4M |
Cost of Goods Sold | 479.9M | 439.8M | 410.1M | 400.1M | 370.7M |
Gross Profit | 207.5M | 184.2M | 180.8M | 165.9M | 137.7M |
Gross Margin % | 30.2% | 29.5% | 30.6% | 29.3% | 27.1% |
Operating Expenses | |||||
Research & Development | - | - | - | - | - |
Selling, General & Administrative | 125.0M | 115.1M | 110.1M | 97.4M | 90.0M |
Other Operating Expenses | - | - | - | - | - |
Total Operating Expenses | 125.0M | 115.1M | 110.1M | 97.4M | 90.0M |
Operating Income | 70.8M | 57.5M | 58.7M | 55.7M | 34.8M |
Operating Margin % | 10.3% | 9.2% | 9.9% | 9.8% | 6.8% |
Non-Operating Items | |||||
Interest Income | - | - | - | - | - |
Interest Expense | 4.4M | 3.8M | 1.8M | 970.0K | 1.2M |
Other Non-Operating Income | -92.0K | -1.4M | 1.9M | -494.0K | 42.0K |
Pre-tax Income | 66.2M | 52.3M | 58.8M | 54.3M | 33.6M |
Income Tax | 19.6M | 13.8M | 15.2M | 12.6M | 9.1M |
Effective Tax Rate % | 29.6% | 26.4% | 25.8% | 23.2% | 27.1% |
Net Income | 46.7M | 38.5M | 43.6M | 41.7M | 24.5M |
Net Margin % | 6.8% | 6.2% | 7.4% | 7.4% | 4.8% |
Key Metrics | |||||
EBITDA | 97.6M | 83.4M | 84.5M | 81.5M | 59.7M |
EPS (Basic) | $6.82 | $5.48 | $6.02 | $5.59 | $3.14 |
EPS (Diluted) | $6.74 | $5.39 | $5.91 | $5.45 | $3.07 |
Basic Shares Outstanding | 6821000 | 7008000 | 7218000 | 7423000 | 7768000 |
Diluted Shares Outstanding | 6821000 | 7008000 | 7218000 | 7423000 | 7768000 |
Income Statement Trend
CRA International Balance Sheet From 2020 to 2024
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Assets | |||||
Current Assets | |||||
Cash & Equivalents | 26.7M | 45.6M | 31.4M | 66.1M | 45.7M |
Short-term Investments | - | - | - | - | - |
Accounts Receivable | 162.3M | 142.7M | 143.6M | 117.0M | 111.6M |
Inventory | - | - | - | - | - |
Other Current Assets | - | - | - | - | - |
Total Current Assets | 269.4M | 265.5M | 248.9M | 249.3M | 220.0M |
Non-Current Assets | |||||
Property, Plant & Equipment | 81.2M | 86.9M | 96.7M | 110.5M | 122.1M |
Goodwill | 194.7M | 195.2M | 194.4M | 182.1M | 183.5M |
Intangible Assets | 7.2M | 7.2M | 8.6M | 4.2M | 5.1M |
Long-term Investments | - | - | - | - | - |
Other Non-Current Assets | 25.8M | 16.3M | 11.4M | 10.8M | 12.4M |
Total Non-Current Assets | 302.1M | 287.7M | 302.1M | 306.0M | 338.5M |
Total Assets | 571.4M | 553.2M | 550.9M | 555.4M | 558.5M |
Liabilities | |||||
Current Liabilities | |||||
Accounts Payable | 28.2M | 28.7M | 27.6M | 23.5M | 19.4M |
Short-term Debt | 18.7M | 16.5M | 16.0M | 14.3M | 13.6M |
Current Portion of Long-term Debt | - | - | - | - | - |
Other Current Liabilities | 14.1M | 12.3M | 12.0M | 12.8M | 9.9M |
Total Current Liabilities | 251.3M | 236.1M | 217.1M | 213.1M | 200.1M |
Non-Current Liabilities | |||||
Long-term Debt | 84.5M | 92.3M | 106.0M | 124.5M | 139.4M |
Deferred Tax Liabilities | 1.2M | 1.1M | 953.0K | 1.0M | 725.0K |
Other Non-Current Liabilities | 22.3M | 11.7M | 15.7M | 10.9M | 9.2M |
Total Non-Current Liabilities | 108.1M | 105.0M | 122.6M | 136.4M | 149.4M |
Total Liabilities | 359.4M | 341.1M | 339.8M | 349.5M | 349.5M |
Equity | |||||
Common Stock | 1.7M | 0 | 1.7M | 0 | 503.0K |
Retained Earnings | 225.5M | 224.3M | 224.4M | 215.8M | 217.0M |
Treasury Stock | - | - | - | - | - |
Other Equity | - | - | - | - | - |
Total Shareholders Equity | 212.1M | 212.1M | 211.2M | 205.8M | 209.0M |
Key Metrics | |||||
Total Debt | 103.2M | 108.8M | 122.0M | 138.8M | 153.0M |
Working Capital | 18.1M | 29.4M | 31.7M | 36.3M | 19.8M |
Balance Sheet Composition
CRA International Cash Flow Statement From 2020 to 2024
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Operating Activities | |||||
Net Income | 46.7M | 38.5M | 43.6M | 41.7M | 24.5M |
Depreciation & Amortization | 26.8M | 25.8M | 25.8M | 25.8M | 24.9M |
Stock-Based Compensation | 5.3M | 4.4M | 4.8M | 4.1M | 3.2M |
Working Capital Changes | -15.9M | -5.8M | -48.5M | 17.1M | -16.8M |
Operating Cash Flow | 60.0M | 58.3M | 25.8M | 89.1M | 37.1M |
Investing Activities | |||||
Capital Expenditures | -16.6M | -2.4M | -3.8M | -2.6M | -17.1M |
Acquisitions | -1.5M | -577.0K | -14.4M | 0 | 0 |
Investment Purchases | - | - | - | - | - |
Investment Sales | - | - | - | - | - |
Investing Cash Flow | -18.1M | -2.9M | -18.2M | -2.6M | -17.1M |
Financing Activities | |||||
Share Repurchases | -33.3M | -31.4M | -27.6M | -45.0M | -13.4M |
Dividends Paid | -12.3M | -10.8M | -9.6M | -8.3M | -7.5M |
Debt Issuance | 102.0M | - | - | - | - |
Debt Repayment | -102.0M | -105.0M | -126.0M | -74.0M | -77.0M |
Financing Cash Flow | -48.9M | -150.3M | -166.4M | -131.2M | -98.7M |
Free Cash Flow | 33.1M | 57.7M | 21.3M | 73.1M | 37.6M |
Net Change in Cash | -7.0M | -95.0M | -158.7M | -44.7M | -78.7M |
Cash Flow Trend
CRA International Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
23.14
Forward P/E
24.88
Price to Book
6.37
Price to Sales
1.77
PEG Ratio
24.88
Profitability Ratios
Profit Margin
7.93%
Operating Margin
10.56%
Return on Equity
29.09%
Return on Assets
9.21%
Financial Health
Current Ratio
0.92
Debt to Equity
113.65
Beta
0.90
Per Share Data
EPS (TTM)
$8.27
Book Value per Share
$30.02
Revenue per Share
$105.65
Peer Financial Comparison
Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
---|---|---|---|---|---|---|
crai | 1.3B | 23.14 | 6.37 | 29.09% | 7.93% | 113.65 |
Verisk Analytics | 37.9B | 42.02 | 121.47 | 243.11% | 30.68% | 1,096.55 |
Equifax | 30.5B | 48.25 | 6.00 | 12.76% | 10.95% | 93.55 |
Icf International | 1.8B | 17.11 | 1.81 | 11.09% | 5.45% | 64.70 |
Diginex | 1.4B | -175.42 | 197.13 | -114.37% | -255.46% | 5.22 |
SBC Medical | 420.1M | 12.78 | 1.72 | 16.44% | 17.71% | 6.35 |
Financial data is updated regularly. All figures are in the company's reporting currency.